Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VALGANCICLOVIR Cause Enterococcal infection? 56 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Enterococcal infection have been filed in association with VALGANCICLOVIR (VALGANCICLOVIR). This represents 0.7% of all adverse event reports for VALGANCICLOVIR.

56
Reports of Enterococcal infection with VALGANCICLOVIR
0.7%
of all VALGANCICLOVIR reports
25
Deaths
49
Hospitalizations

How Dangerous Is Enterococcal infection From VALGANCICLOVIR?

Of the 56 reports, 25 (44.6%) resulted in death, 49 (87.5%) required hospitalization, and 13 (23.2%) were considered life-threatening.

Is Enterococcal infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VALGANCICLOVIR. However, 56 reports have been filed with the FAERS database.

What Other Side Effects Does VALGANCICLOVIR Cause?

Off label use (1,882) Cytomegalovirus infection (1,091) Drug ineffective (886) Neutropenia (809) Leukopenia (574) Drug resistance (524) Cytomegalovirus viraemia (447) Pancytopenia (434) Cytomegalovirus infection reactivation (374) Death (359)

What Other Drugs Cause Enterococcal infection?

TACROLIMUS (733) METHYLPREDNISOLONE (500) MYCOPHENOLATE MOFETIL (460) PREDNISONE (434) CYCLOPHOSPHAMIDE (407) RITUXIMAB (357) PREDNISOLONE (299) CYCLOSPORINE (293) METHOTREXATE (264) DEXAMETHASONE (260)

Which VALGANCICLOVIR Alternatives Have Lower Enterococcal infection Risk?

VALGANCICLOVIR vs VALIUM VALGANCICLOVIR vs VALPROATE VALGANCICLOVIR vs VALPROIC ACID VALGANCICLOVIR vs VALPROMIDE VALGANCICLOVIR vs VALSARTAN

Related Pages

VALGANCICLOVIR Full Profile All Enterococcal infection Reports All Drugs Causing Enterococcal infection VALGANCICLOVIR Demographics